Kate Birchall has been appointed head of Asia Pacific for LCH Ltd, effective 15 October 2018.
Based in Sydney, she will report to Martin Pluves, CEO, LCH Ltd, and will be responsible for LCH’s business in Asia Pacific, including the CCP’s existing OTC derivatives clearing operations in Sydney and Tokyo.
LCH says Asia Pacific is a region of strategic growth for the firm, which is directly licenced in Australia, Hong Kong, Japan, Singapore. Members and clients from 12 APAC countries currently use LCH’s clearing services. ?
Birchall joins LCH from National Australia Bank (NAB), where she was most recently head of portfolio optimisation and collateral. Prior to her time at NAB, she was a director at KPMG and has also held various roles at Lloyds, CIBC and ANZ. ?
Birchall is replacing Marcus Robinson, who has moved from Asia to assume the position of LCH head of group business development, based in London. In his new role, Robinson is responsible for defining new business opportunities by engaging clients across services to identify and develop new services and products. He reports to Daniel Maguire, CEO, LCH Group. ?
“I’m pleased to welcome Kate to LCH as Head of Asia Pacific,” says Pluves. “She brings with her substantial experience of the markets in Australia and internationally, and will be an asset to our leadership team. In her new role she will oversee our growing business in Asia Pacific, fostering relationships with market participants in the region, and leading our colleagues based in Australia and Japan.”